Roivant Sciences Ltd. Earnings

Roivant Sciences Ltd.’s revenue fell -73.83% since last year same period to $7.57Mn in the Q1 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -16.06% fall in its revenue since last 3-months.

Roivant Sciences Ltd.’s net profit fell -36.63% since last year same period to $-206.48Mn in the Q1 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -221.9% fall in its net profits since last 3-months.

Roivant Sciences Ltd.’s net profit margin fell -422.17% since last year same period to -2727.54% in the Q1 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -245.22% fall in its net profit margins since last 3-months.

Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a 31.96% jump from last quarter’s estimates.

Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current year stand at -0.16.

Roivant Sciences Ltd.’s earning per share (EPS) fell -14.89% since last year same period to -0.22 in the Q1 2025. This indicates that the Roivant Sciences Ltd. has generated -14.89% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Roivant Sciences Ltd.’s return on assets (ROA) stands at -0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Roivant Sciences Ltd.’s return on equity (ROE) stands at -0.13.